236 related articles for article (PubMed ID: 32641647)
1. Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis.
Yoshikawa N; Matsubara E; Yamamoto M; Yamazaki H; Uehara M; Kamata M; Tanaka H
Intern Med; 2020 Oct; 59(20):2611-2618. PubMed ID: 32641647
[TBL] [Abstract][Full Text] [Related]
2. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
Williams VL; Cohen PR
Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
[TBL] [Abstract][Full Text] [Related]
3. Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.
Shovman O; Tamar S; Amital H; Watad A; Shoenfeld Y
Clin Rheumatol; 2018 Feb; 37(2):563-568. PubMed ID: 29063464
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports.
Boussemart L; Jacobelli S; Batteux F; Goulvestre C; Grange P; Carlotti A; Morini JP; Gorin I; Ziza JM; Avril MF; Dupin N
Dermatology; 2010; 221(3):201-5. PubMed ID: 20720390
[TBL] [Abstract][Full Text] [Related]
5. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
[No Abstract] [Full Text] [Related]
6. What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.
Takase K; Horton SC; Ganesha A; Das S; McHugh A; Emery P; Savic S; Buch MH
Ann Rheum Dis; 2014 Sep; 73(9):1695-9. PubMed ID: 24854356
[TBL] [Abstract][Full Text] [Related]
7. Adalimumab-induced lupus erythematosus.
Martín JM; Ricart JM; Alcácer J; Rausell N; Arana G
Lupus; 2008 Jul; 17(7):676-8. PubMed ID: 18625641
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Bae SC
Int J Rheum Dis; 2016 Nov; 19(11):1103-1111. PubMed ID: 26692536
[TBL] [Abstract][Full Text] [Related]
9. [A man with skin lesions of his face].
Mutsaers ER; Kloppenburg G; Lavrijsen AP
Ned Tijdschr Geneeskd; 2016; 160():A9980. PubMed ID: 27353155
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab.
Diaz JC; Vallejo S; Cañas CA
Rheumatol Int; 2012 Oct; 32(10):3315-7. PubMed ID: 21881980
[TBL] [Abstract][Full Text] [Related]
11. IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions.
Woodrick RS; Ruderman EM
Bull NYU Hosp Jt Dis; 2012; 70(3):195-9. PubMed ID: 23259628
[TBL] [Abstract][Full Text] [Related]
12. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
Li N; Betts KA; Messali AJ; Skup M; Garg V
Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
[TBL] [Abstract][Full Text] [Related]
13. Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
Chen YC; Chiu WC; Su FM; Chen JF
Int J Rheum Dis; 2018 Sep; 21(9):1695-1700. PubMed ID: 29024421
[TBL] [Abstract][Full Text] [Related]
14. Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
Iannone F; Ferraccioli G; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Gorla R; Bazzani C; Govoni M; Farina I; Gremese E; Carletto A; Giollo A; Galeazzi M; Foti R; Bianchino L; La Grasta L; Lapadula G
Clin Rheumatol; 2018 Feb; 37(2):315-321. PubMed ID: 28980085
[TBL] [Abstract][Full Text] [Related]
15. TNF-inhibitor induced lupus in a patient treated with adalimumab for rheumatoid arthritis.
Lieberman MR; Liebman TN; Alapati U; Khachemoune A
Dermatol Online J; 2014 Dec; 21(2):. PubMed ID: 25756476
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour necrosis factor α-induced lupus erythematosus panniculitis.
Durand AL; Goussot JF; Thiolat D; Taieb A; Marie J; Seneschal J; Darrigade AS
J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):e318-e319. PubMed ID: 28045205
[No Abstract] [Full Text] [Related]
17. TNF-alpha antagonist induced lupus on three different agents.
Mudduluru BM; Shah S; Shamah S; Swaminath A
Postgrad Med; 2017 Mar; 129(2):304-306. PubMed ID: 27748629
[TBL] [Abstract][Full Text] [Related]
18. Lupus attributable to anti-TNF therapy and revealed by interstitial granulomatous dermatitis.
Guerin M; Haettich B; Bara C; Artru L; Prophette B; Célérier P; Maillard H
Rheumatol Int; 2012 Sep; 32(9):2937-40. PubMed ID: 21800115
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
Silvagni E; Bortoluzzi A; Carrara G; Zanetti A; Govoni M; Scirè CA
BMJ Open; 2018 Sep; 8(9):e021447. PubMed ID: 30206082
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF therapy-induced lupus erythematosus-like syndrome in a patient treated with adalimumab for cutaneous psoriasis.
Stein JE; Patterson-Fortin J; Bodnar BE
BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29654101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
